AC Immune SA Quarterly Research And Development Expense in CHF from Q1 2017 to Q2 2023

Taxonomy & unit
ifrs-full: CHF
Summary
AC Immune SA annual/quarterly Research And Development Expense history and growth rate from Q1 2017 to Q2 2023.
  • AC Immune SA Research And Development Expense for the quarter ending June 30, 2023 was ₣13.7M, a 12.8% decline year-over-year.
  • AC Immune SA annual Research And Development Expense for 2023 was ₣54.6M, a 9.5% decline from 2022.
  • AC Immune SA annual Research And Development Expense for 2022 was ₣60.3M, a 3.12% decline from 2021.
  • AC Immune SA annual Research And Development Expense for 2021 was ₣62.3M, a 4.7% increase from 2020.
Research And Development Expense, Trailing 12 Months (CHF)
Research And Development Expense, Quarterly (CHF)
Research And Development Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 13.7M -2.01M -12.8% Apr 1, 2023 Jun 30, 2023 6-K 2023-08-04
Q3 2022 14.4M -733K -4.85% Jul 1, 2022 Sep 30, 2022 6-K 2022-10-28
Q2 2022 15.7M Apr 1, 2022 Jun 30, 2022 6-K 2023-08-04
Q3 2021 15.1M Jul 1, 2021 Sep 30, 2021 6-K 2022-10-28
Q4 2018 44.3M 12.1M +1.95M +19.2% Oct 1, 2018 Dec 31, 2018 20-F 2019-03-21
Q3 2018 42.3M 11.5M +3.35M +40.9% Jul 1, 2018 Sep 30, 2018 20-F 2019-03-21
Q2 2018 39M 10.5M +3.7M +54% Apr 1, 2018 Jun 30, 2018 20-F 2019-03-21
Q1 2018 35.3M 10.1M +2.62M +35.1% Jan 1, 2018 Mar 31, 2018 20-F 2019-03-21
Q4 2017 32.7M 10.2M Oct 1, 2017 Dec 31, 2017 20-F 2019-03-21
Q3 2017 8.2M Jul 1, 2017 Sep 30, 2017 20-F 2019-03-21
Q2 2017 6.84M Apr 1, 2017 Jun 30, 2017 20-F 2019-03-21
Q1 2017 7.45M Jan 1, 2017 Mar 31, 2017 20-F 2019-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.